Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • JonB
    Member
    • Jan 2010
    • 85

    #1

    Illumina RNA-seq: should I trim low quality bases prior to mapping?

    I have Illumina sequences from a cDNA sample. I want to map the reads to a reference genome and calculate expression levels. I think I will map using bowtie/tophat.

    The adaptors are removed from my sequences, but I wonder whether I need to trim away the low quality bases at the 3'-end of the reads? Or is this taken into account in the mapping?

    Thanks!
  • pbluescript
    Senior Member
    • Nov 2009
    • 224

    #2
    Tophat can sometimes have trouble mapping reads with a lot of low quality bases on the end. Trimming the reads might help with that, but shorter reads are more likely to map to multiple locations. If they are paired end reads, you will need to reassess your mean inner distance. Try it with and without the trimming and see which works best for your data.
    STAR is another alignment program you might consider trying that will automatically soft clip bases off a read if necessary to find a good alignment.

    Comment

    Latest Articles

    Collapse

    • SEQadmin2
      16S/ITS Profiling vs. Shotgun Metagenomics: What Changes in Your Workflow?
      by SEQadmin2




      NGS has revolutionized clinical microbiology by offering new ways to identify and surveil pathogens without prior knowledge of the target. One popular approach is 16S rRNA and ITS amplicon sequencing, which targets specific microbial markers. But studies are increasingly incorporating shotgun metagenomics, a technique that sequences all DNA from a sample without targeting specific microbial markers. This approach allows more detailed taxonomic classification, detection...
      Yesterday, 06:46 AM
    • SEQadmin2
      Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
      by SEQadmin2



      Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

      Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
      ...
      10-14-2026, 09:55 AM

    ad_right_rmr

    Collapse

    News

    Collapse

    Topics Statistics Last Post
    Started by SEQadmin2, 10-28-2026, 09:57 AM
    0 responses
    25 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-28-2026, 09:51 AM
    0 responses
    15 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-22-2026, 11:13 AM
    0 responses
    71 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-22-2026, 10:48 AM
    0 responses
    48 views
    0 reactions
    Last Post SEQadmin2  
    Working...